Results 261 to 270 of about 988,166 (377)

Studies on the Treatment of Malignant Tumors With Fibroblasts Inhibiting Agents

, 1963
Kiyoshi Hiraki, Ikuro Kimura, Zensuke Ota, Kenwo Asano, Hiroshi Kageyama, Koichi Shibuya, Hidenari Kotani, Ryozo Matsuura, Junichiro Tsuchida, Tatsuo Sezaki, Toshinobu Hiraoka, Hajime Himei, Yoshiaki Moritani, Masatoshi Yamana   +13 more
openalex   +2 more sources

Type II hyperprolinemia. Delta1-pyrroline-5-carboxylic acid dehydrogenase deficiency in cultured skin fibroblasts and circulating lymphocytes. [PDF]

, 1976
David Valle, Stephen I. Goodman, Derek A. Applegarth, Vivian E. Shih, James M. Phang   +4 more
openalex   +1 more source

Biohybrid Vascular Graft Made of Textile‐Reinforced Elastin‐Like Recombinamers and Its Preservation via Drying Processes

Advanced Healthcare Materials, EarlyView.
Clinical translation of biohybrid medical implants requires the previous implementation of drying schemes that can facilitate their sterilization and storage. This study addresses that critical aspect and elucidates the impact of drying on biohybrid vascular grafts, highlighting the need for implant‐specific drying strategies to ensure safety ...
Dominic Pascal Andre, Stephan Ruetten, José Carlos Rodríguez‐Cabello, Stefan Jockenhoevel, Thomas Schmitz‐Rode, Alicia Fernández‐Colino   +5 more
wiley   +1 more source

The mechanism by which MALAT1/CREG1 regulates premature rupture of fetal membrane through autophagy mediated differentiation of amniotic fibroblasts. [PDF]

Noncoding RNA Res
Huang X, Huang T, Chen A, Shao Y.
europepmc   +1 more source

Studies on the Treatment of Malignant Tumors with Fibroblast-Inhibiting Agent

, 1965
Hidenari Kodani
openalex   +2 more sources

Light‐Activatable Hyaluronic Acid‐Derivatives Releasing Nitric Oxide and Their Delivery in the Skin

Advanced Healthcare Materials, EarlyView.
This work explores the development of photoactivatable hyaluronic acid (HA) derivatives functionalized with nitric oxide (NO) photodonors for light‐controlled therapeutic applications. The HA derivatives demonstrate enhanced keratinocyte proliferation and migration, effective NO release, and skin penetration when formulated as microemulsions.
Giuseppe Longobardi, Cristina Parisi, Federica Sodano, Ovidio Catanzano, Anna Di Porzio, Antonio Randazzo, Salvatore Sortino, Fabiana Quaglia   +7 more
wiley   +1 more source

Modeling Stromal Cells Inside the Tumor Microenvironment of Ovarian Cancer: In Vitro Generation of Cancer-Associated Fibroblast-Like Cells and Their Impact in a 3D Model. [PDF]

MedComm (2020)
Romoli J, Chiodelli P, Signoroni PB, Vertua E, Ferrari C, Giuzzi E, Paini A, Scalvini E, Papait A, Stefani FR, Silini AR, Parolini O.   +11 more
europepmc   +1 more source

Studies on the Treatment of Chronic Hepatic Disorders with Fibroblast-inhibiting Agents

, 1965
Masatoshi Yamana
openalex   +2 more sources

Tumor‐Targeted Exosome‐Based Heavy Atom‐Free Nanosensitizers With Long‐Lived Excited States for Safe and Effective Sono‐Photodynamic Therapy of Solid Tumors

Advanced Healthcare Materials, EarlyView.
Engineered exosome‐based heavy atom‐free nanosensitizers are developed for safe and targeted sono‐photodynamic therapy of solid tumors. The IR820‐TPE‐loaded, biotin‐conjugated exosomes (IR820‐TPE@B‐Exo) demonstrate significant promise for NIR fluorescence imaging‐guided sono‐photodynamic cancer therapy.
Van‐Nghia Nguyen, Thuy Giang Nguyen Cao, Hyunsun Jeong, Quan Truong Hoang, Binh T. T. Pham, Jieun Bang, Chang Woo Koh, Ji Hee Kang, Jeong Hyun Lee, Xiaofeng Wu, Won Jong Rhee, Young Tag Ko, K. M. K. Swamy, Sungnam Park, JaeHong Park, Min Suk Shim, Juyoung Yoon   +16 more
wiley   +1 more source

Spatial dissection of tumour microenvironments in gastric cancers reveals the immunosuppressive crosstalk between <i>CCL2+</i> fibroblasts and <i>STAT3</i>-activated macrophages. [PDF]

Gut
Lee SH, Lee D, Choi J, Oh HJ, Ham IH, Ryu D, Lee SY, Han DJ, Kim S, Moon Y, Song IH, Song KY, Lee H, Lee S, Hur H, Kim TM.   +15 more
europepmc   +1 more source